<html>
<head>
    <meta http-equiv="Access-Control-Allow-Origin" content="*"/>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Barlow:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Lora:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,600;1,700&display=swap"
          rel="stylesheet">
    <!--    <link rel="stylesheet" type="text/css" href="harp.css">-->
    <script src="paged.polyfill.js"></script>
    <style>
        @page {
            size: A4;
            margin: 0;
        }

        @media print {
            body {
                margin: 0
            }
        }

        div {
            display: block;
        }

        h1, h2, h3, h4, h5 {
            margin: 0;
            font-family: "Barlow";

        }

        .header-main {
            background-color: #bb2930;
            width: 100%;
            height: 1in;
        }

        .temp-box {
            background-color: #d9dadb;
            border-radius: 10px;
            width: 100%;
        }

        .logo-doh {
            content: url("D:/ohasis-conso/src/reports/harp/logo_doh.png");
        }

        .title-page {
            font-size: 14pt;
            font-family: "Barlow";
        }

        h1.heading-section {
            font-size: 14pt;
            color: #c12428;
            width: 100%;
            text-align: center;
        }

        .full-width {
            width: 100%;
            display: flex;
        }

        .column-left {
            width: 50%;
            padding-left: 12mm;
            padding-right: 3mm;
            display: inline-block;
        }

        .column-right {
            width: 50%;
            padding-right: 12mm;
            padding-left: 3mm;
            display: inline-block;
        }

        .narrative {
            font-family: "Lora";
            font-size: 7.85pt;
            text-align: justify;
            margin: 0;
        }

        table.figure-label {
            font-family: "Barlow";
            font-size: 8.5pt;
            font-weight: 600;
            border-collapse: collapse;
            width: 100%;
        }

        td.tabfig-num {
            width: 12mm;
            color: #d83029;
            padding: 0;
        }

        td.tabfig-colon {
            width: 3mm;
            color: #d83029;
            padding: 0;
        }

        td.tabfig-title {
            width: auto;
            padding: 0;
        }
    </style>
</head>
<body>
<!--<img src="D:/ohasis-conso/src/reports/harp/template_p1.png" style="width: 100%; opacity: .4; position: absolute;">-->
<div class="header-main" style="height: 1in; padding: .07in 12mm; margin-bottom: 1mm">
    <img class="logo-doh" style="height: .9in; float: left">
    <div style="padding: .12in 0 .12in .95in; display: block; width: 100%">
        <div style="display: block; width: 100%">
            <div style="float: left">
                <h1 class="title-page" style="color: #fed340">Department of Health | Epidemiology Bureau</h1>
            </div>
            <div style="float: right">
                <h1 class="title-page" style="color: #f9f5e8; text-align: right; font-size: 13pt">APRIL-JUNE 2023</h1>
            </div>
        </div>
        <div style="display: flex; width: 100%">
            <h1 class="title-page" style="color: #f9f5e8; font-size: 21.7pt">
                HIV & AIDS SURVEILLANCE OF THE PHILIPPINES
            </h1>
        </div>
    </div>
</div>
<h1 class="heading-section">HIV & AIDS CONTINUUM OF CARE</h1>
<div class="full-width" style="margin-bottom: 4mm">
    <div class="column-left">
        <p class="narrative" style="margin-bottom: 2.5mm">
            The latest Philippine HIV estimates show that by the end of 2023,
            there will be 189,000 estimated People Living with HIV (PLHIV)
            in the country.
            <br>
            <br>
            Of the estimated PLHIV, 111,031 (59%) cases have been diagnosed or
            laboratory-confirmed and currently living or not reported to have
            died, as of June 2023. Further, 70,916 PLHIV are currently on lifesaving
            Anti-retroviral Therapy (ART), of which, 26,006 (37%) PLHIV have
            been tested for viral load (VL) in the past 12 months. Among those tested
            for VL, 22,690 (87%) are virally suppressed [Figure 1].
        </p>

        <table class="figure-label" style="margin-bottom: 2.5mm">
            <td class="tabfig-num">Figure 1</td>
            <td class="tabfig-colon">:</td>
            <td class="tabfig-title">National HIV Care Cascade, as of June 2023</td>
        </table>

        <div class="temp-box" style="height: 280px"></div>
    </div>
    <div class="column-right">
        <h1 class="narrative">
            95-95-95 ACCOMPLISHMENT, as of June 2023
        </h1>
    </div>
</div>
<div class="full-width" style="padding: 0 12mm">
    <p class="narrative">
        Eighty percent of the estimated PLHIV cases in the country are concentrated in six regions: National Capital
        Region (NCR), CALABARZON (Region 4A),
        Central Luzon (Region 3), Central Visayas (Region 7), Western Visayas (Region 6), and Davao Region (Region 11).
        The diagnosis and treatment coverage
        varied by region of residence. As of June 2023, all regions have â‰¥50% diagnosis coverage among estimated PLHIV;
        while treatment coverage across
        the regions was >55% except for Regions 7, 9, and BARMM. The viral load testing coverage among PLHIV on ART
        ranged from 15% to 47%; while viral
        suppression among tested ranged from 75% - 92% (Table 2).
    </p>
</div>
</body>
</html>

